These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
511 related articles for article (PubMed ID: 28581401)
1. Prospective Study of Hippocampal-Sparing Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer. Redmond KJ; Hales RK; Anderson-Keightly H; Zhou XC; Kummerlowe M; Sair HI; Duhon M; Kleinberg L; Rosner GL; Vannorsdall T Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):603-611. PubMed ID: 28581401 [TBL] [Abstract][Full Text] [Related]
2. Treatment Design and Rationale for a Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for SCLC: PREMER Trial on Behalf of the Oncologic Group for the Study of Lung Cancer/Spanish Radiation Oncology Group-Radiation Oncology Clinical Research Group. Rodríguez de Dios N; Couñago F; López JL; Calvo P; Murcia M; Rico M; Vallejo C; Luna J; Trueba I; Cigarral C; Farre N; Manero RM; Durán X; Samper P Clin Lung Cancer; 2018 Sep; 19(5):e693-e697. PubMed ID: 29891263 [TBL] [Abstract][Full Text] [Related]
3. Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study. Rodríguez de Dios N; Couñago F; Murcia-Mejía M; Rico-Oses M; Calvo-Crespo P; Samper P; Vallejo C; Luna J; Trueba I; Sotoca A; Cigarral C; Farré N; Manero RM; Durán X; Gispert JD; Sánchez-Benavides G; Rognoni T; Torrente M; Capellades J; Jiménez M; Cabada T; Blanco M; Alonso A; Martínez-San Millán J; Escribano J; González B; López-Guerra JL J Clin Oncol; 2021 Oct; 39(28):3118-3127. PubMed ID: 34379442 [TBL] [Abstract][Full Text] [Related]
4. A prospective evaluation of whole brain volume loss and neurocognitive decline following hippocampal-sparing prophylactic cranial irradiation for limited-stage small-cell lung cancer. Gui C; Chintalapati N; Hales RK; Voong KR; Sair HI; Grimm J; Duhon M; Kleinberg LR; Vannorsdall TD; Redmond KJ J Neurooncol; 2019 Sep; 144(2):351-358. PubMed ID: 31302830 [TBL] [Abstract][Full Text] [Related]
5. Analyses of distribution and dosimetry of brain metastases in small cell lung cancer with relation to the neural stem cell regions: feasibility of sparing the hippocampus in prophylactic cranial irradiation. Zhao L; Shen Y; Guo JD; Gu HL; Yu W; Wang JM; Lv CX; Liu J; Cai XW; Fu XL Radiat Oncol; 2017 Jul; 12(1):118. PubMed ID: 28709456 [TBL] [Abstract][Full Text] [Related]
6. Risk of hippocampal metastases in small cell lung cancer patients at presentation and after cranial irradiation: a safety profile study for hippocampal sparing during prophylactic or therapeutic cranial irradiation. Kundapur V; Ellchuk T; Ahmed S; Gondi V Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):781-6. PubMed ID: 25752392 [TBL] [Abstract][Full Text] [Related]
7. Study protocol: watchful observation of patients with limited small cell lung cancer instead of the PCI-prospective, multi-center one-arm study. Nawrocki S; Sugajska A BMC Cancer; 2020 Mar; 20(1):231. PubMed ID: 32188425 [TBL] [Abstract][Full Text] [Related]
8. Patterns of brain metastasis immediately before prophylactic cranial irradiation (PCI): implications for PCI optimization in limited-stage small cell lung cancer. Chu X; Li S; Xia B; Chu L; Yang X; Ni J; Zou L; Li Y; Xie C; Lin J; Zhu Z Radiat Oncol; 2019 Sep; 14(1):171. PubMed ID: 31533763 [TBL] [Abstract][Full Text] [Related]
9. Prophylactic cranial irradiation for patients with limited-stage small-cell lung cancer with response to chemoradiation. Tai P; Assouline A; Joseph K; Stitt L; Yu E Clin Lung Cancer; 2013 Jan; 14(1):40-4. PubMed ID: 22673624 [TBL] [Abstract][Full Text] [Related]
10. Re-evaluation of prophylactic cranial irradiation in limited-stage small cell lung cancer: a propensity score matched analysis. Inoue Y; Tsujino K; Sulaiman NS; Marudai M; Kajihara A; Miyazaki S; Sekii S; Uezono H; Ota Y; Soejima T J Radiat Res; 2021 Sep; 62(5):877-883. PubMed ID: 34230962 [TBL] [Abstract][Full Text] [Related]
11. Intracranial failure after hippocampal-avoidance prophylactic cranial irradiation in limited-stage small-cell lung cancer patients. Cho Y; Lee J; Lee IJ; Kim JW; Baek JG; Jung DM; Cho BC; Hong MH; Kim HR; Lee CG; Yoon HI Sci Rep; 2021 Apr; 11(1):7435. PubMed ID: 33795826 [TBL] [Abstract][Full Text] [Related]
12. Hippocampal dosimetry correlates with the change in neurocognitive function after hippocampal sparing during whole brain radiotherapy: a prospective study. Tsai PF; Yang CC; Chuang CC; Huang TY; Wu YM; Pai PC; Tseng CK; Wu TH; Shen YL; Lin SY Radiat Oncol; 2015 Dec; 10():253. PubMed ID: 26654128 [TBL] [Abstract][Full Text] [Related]
13. Prophylactic Cranial Irradiation for Limited-Stage Small-Cell Lung Cancer Patients: Secondary Findings From the Prospective Randomized Phase 3 CONVERT Trial. Levy A; Le Péchoux C; Mistry H; Martel-Lafay I; Bezjak A; Lerouge D; Padovani L; Taylor P; Faivre-Finn C J Thorac Oncol; 2019 Feb; 14(2):294-297. PubMed ID: 30292850 [TBL] [Abstract][Full Text] [Related]
14. Treatment Response and Prophylactic Cranial Irradiation Are Prognostic Factors in a Real-life Limited-disease Small-cell Lung Cancer Patient Cohort Comprehensively Staged With Cranial Magnetic Resonance Imaging. Eze C; Roengvoraphoj O; Niyazi M; Hildebrandt G; Fietkau R; Belka C; Manapov F Clin Lung Cancer; 2017 Jul; 18(4):e243-e249. PubMed ID: 28065620 [TBL] [Abstract][Full Text] [Related]
16. Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial. Takahashi T; Yamanaka T; Seto T; Harada H; Nokihara H; Saka H; Nishio M; Kaneda H; Takayama K; Ishimoto O; Takeda K; Yoshioka H; Tachihara M; Sakai H; Goto K; Yamamoto N Lancet Oncol; 2017 May; 18(5):663-671. PubMed ID: 28343976 [TBL] [Abstract][Full Text] [Related]
17. Management of brain metastasis with magnetic resonance imaging and stereotactic irradiation attenuated benefits of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer. Ozawa Y; Omae M; Fujii M; Matsui T; Kato M; Sagisaka S; Asada K; Karayama M; Shirai T; Yasuda K; Nakamura Y; Inui N; Yamada K; Yokomura K; Suda T BMC Cancer; 2015 Aug; 15():589. PubMed ID: 26275617 [TBL] [Abstract][Full Text] [Related]
18. Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) - a phase II prospective randomized multicenter trial (NOA-14, ARO 2015-3, DKTK-ROG). Grosu AL; Frings L; Bentsalo I; Oehlke O; Brenner F; Bilger A; Fennell JT; Rothe T; Schneider-Fuchs S; Graf E; Schmoor C; Beck J; Becker G; Bock M; Egger K; Urbach H; Lahmann C; Popp I BMC Cancer; 2020 Jun; 20(1):532. PubMed ID: 32513138 [TBL] [Abstract][Full Text] [Related]
19. Prophylactic cranial irradiation in elderly patients with small cell lung cancer: findings from a North Central Cancer Treatment Group pooled analysis. Rule WG; Foster NR; Meyers JP; Ashman JB; Vora SA; Kozelsky TF; Garces YI; Urbanic JJ; Salama JK; Schild SE J Geriatr Oncol; 2015 Mar; 6(2):119-26. PubMed ID: 25482023 [TBL] [Abstract][Full Text] [Related]
20. Rational and design of prophylactic cranial irradiation (PCI) and brain MRI surveillance versus brain MRI surveillance alone in patients with limited-stage small cell lung cancer achieving complete remission (CR) of tumor after chemoradiotherapy: a multicenter prospective randomized study. Chen M; Li R; Kong Y; Shi L; Wang J; Wang Y; Xu Y; Ji Y; Hu X BMC Cancer; 2024 Apr; 24(1):429. PubMed ID: 38589800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]